These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3311782)

  • 1. Pancreatic beta cell function in polycystic ovary syndrome: its relationship to body weight, serum testosterone and serum prolactin levels.
    Prelević GM; Würzburger MI; Perić LA
    Exp Clin Endocrinol; 1987 Aug; 90(1):76-82. PubMed ID: 3311782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
    Weber RF; Pache TD; Jacobs ML; Docter R; Loriaux DL; Fauser BC; Birkenhäger JC
    Clin Endocrinol (Oxf); 1993 Mar; 38(3):295-300. PubMed ID: 8458101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance in nonobese patients with polycystic ovarian disease.
    Chang RJ; Nakamura RM; Judd HL; Kaplan SA
    J Clin Endocrinol Metab; 1983 Aug; 57(2):356-9. PubMed ID: 6223044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.
    Dunaif A; Mandeli J; Fluhr H; Dobrjansky A
    J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R; Gambineri A; Anconetani B; Vicennati V; Colitta D; Caramelli E; Casimirri F; Morselli-Labate AM
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):517-27. PubMed ID: 10468913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
    Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
    J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of relationship between 17-hydroxyprogesterone response to buserelin testing and hyperinsulinemia in polycystic ovary syndrome.
    Sahin Y; Ayata D; Keleştimur F
    Eur J Endocrinol; 1997 Apr; 136(4):410-5. PubMed ID: 9150702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LH pulsatility and response to a single s.c. injection of buserelin in polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Peric L
    Gynecol Endocrinol; 1990 Mar; 4(1):1-13. PubMed ID: 2110712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome.
    Gonzalez F; Thusu K; Abdel-Rahman E; Prabhala A; Tomani M; Dandona P
    Metabolism; 1999 Apr; 48(4):437-41. PubMed ID: 10206434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between hormonal and metabolic profiles in women with polycystic ovary syndrome].
    Esposito V; Federico P; Lo Iudice G; Rispoli C; Sabatino P; D'Alessandro B
    Minerva Endocrinol; 1992; 17(1):21-9. PubMed ID: 1495451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?
    Maliqueo M; Atwater I; Lahsen R; Pérez-Bravo F; Angel B; Sir-Petermann T
    Hum Reprod; 2003 Dec; 18(12):2683-8. PubMed ID: 14645192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin levels in women with polycystic ovary syndrome: their relationship to body weight and insulin levels.
    Tropeano G; Vuolo IP; Lucisano A; Liberale L; Barini A; Carfagna P; Caroli G; Menini E; dell'Acqua S
    J Endocrinol Invest; 1996 Mar; 19(3):139-45. PubMed ID: 8743278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-four-hour serum growth hormone, insulin, C-peptide and blood glucose profiles and serum insulin-like growth factor-I concentrations in women with polycystic ovaries.
    Prelević GM; Wurzburger MI; Balint-Perić L; Ginsburg J
    Horm Res; 1992; 37(4-5):125-31. PubMed ID: 1490653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma androgens and oestradiol during oral glucose tolerance test in patients with polycystic ovaries.
    Tiitinen A; Pekonen F; Stenman UH; Laatikainen T
    Hum Reprod; 1990 Apr; 5(3):242-5. PubMed ID: 2191000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome: obesity, insulin resistance, hyperandrogenism.
    Lo Dico G; Alongi G; Savatteri L; Rini GB; Mascellino MR; Di Fede G; Rizzo G
    Acta Eur Fertil; 1989; 20(5):309-13. PubMed ID: 2700062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
    Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
    J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.